VERONICA WILLIAMS: Open Payments
NPI 1912618786 · RUSHVILLE, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,075 in 123 payments from 11 companies in 2025. Trend: 2023 $1,249 · 2024 $1,531 · 2025 $2,075
Food & beverage: $1,957Education: $119
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 15 | $347 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 22 | $331 |
| ABBVIE INC. | 28 | $267 |
| Alkermes, Inc. | 15 | $255 |
| E.R. Squibb & Sons, L.L.C. | 10 | $226 |
| Vanda Pharmaceuticals Inc. | 8 | $223 |
| Otsuka America Pharmaceutical, Inc. | 13 | $174 |
| Collegium Pharmaceutical, Inc. | 4 | $82 |
| Janssen Pharmaceuticals, Inc | 4 | $66 |
| Axsome Therapeutics, Inc. | 2 | $52 |
Products named: CAPLYTA, VRAYLAR, ARISTADA, COBENFY, FANAPT, UZEDY, Jornay PM, ABILIFY ASIMTUFII.
Industry payments across IL — which companies pay providers there.
